A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers
RESPOND-HCW
A Scalable Low-intensity Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers Involved in the First COVID-19 Outbreak in Spain: a Randomized Trial
1 other identifier
interventional
232
1 country
2
Brief Summary
Rationale: The COVID-19 pandemic has impacted the mental health of healthcare workers (HCWs). This study combines two low-intensity psychological interventions developed by the World Health Organization (Doing What Matters \[DWM\] and Problem Management Plus \[PM+\]) into a stepped-care program for HCWs. Objective: The main objective is to evaluate the implementation and (cost-)effectiveness of the culturally and contextually adapted DWM/PM+ stepped-care programs amongst health care workers during the COVID-19 pandemic in terms of mental distress, resilience, wellbeing, health inequalities, and costs to health systems. Study design: Phase 2 (intervention study): pragmatic implementation trial with a single-blinded, randomized, parallel-group design. Phase 3: qualitative process evaluation consisting of individual interviews and focus group discussions (FGDs). Study population: Study phase 2: Health care workers with self-reported elevated psychological distress. Study phase 3: study participants with different trajectories through the trial (completers, non-completers, drop-outs, etc.), family members/close persons of participants, professionals, and facilitators of the DWM and PM+ intervention. Intervention- study phase 2: All participants (in both the treatment and the comparison group) will receive Psychological First Aid (PFA) and care as usual (CAU). In addition to PFA and CAU, the treatment group will receive the stepped-care intervention (DWM with or without PM+) in addition to CAU. The stepped-care intervention consists of DWM (step 1) and conditionally PM+ (step 2) if participants still meet criteria for psychological distress (Kessler Psychological Distress scale (K10) \>15.9) 1 month after having received DWM. Main study parameters/endpoints: Phase 2: Screening for in- and exclusion criteria will be interviewer-administered, in-person or through (video) calls. Online assessments will take place at baseline, at 2 weeks after having received DWM, at 1 week and at 2 months after having received PM+. The main study parameter will be the decrease in symptoms of anxiety and depression from baseline to two-month follow-up, measured through the sum score of the Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder-7 (GAD-7), i.e. the PHQ-Anxiety and Depression Score (PHQ-ADS). Phase 3: Through FGDs and interviews at the end of the study, the feasibility of scaling-up the implementation on the stepped-care DWM/PM+ intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedStudy Start
First participant enrolled
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedJune 4, 2025
November 1, 2021
10 months
July 16, 2021
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
The PHQ-ADS is a 16-item self-reported instrument that combines the nine-item Patient Health Questionnaire depression scale and seven-item Generalized Anxiety Disorder scale-as a composite measure of depression and anxiety. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 48, with higher scores indicating higher levels of depression and anxiety symptomatology.
Change from baseline to 20 weeks
Secondary Outcomes (7)
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Change: Baseline, 6 weeks, and 12 weeks
Patient Health Questionnaire (PHQ-9)
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
Generalized Anxiety Disorder (GAD-7) scale
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
Posttraumatic Stress Disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5) - 8-item version
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
EuroQol 5-dimensional descriptive system - 5-level version (EQ-5D-5L)
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
- +2 more secondary outcomes
Other Outcomes (2)
Satisfaction with the intervention
20 weeks
Positive Appraisal Style
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
Study Arms (2)
Stepped-care program (Step 1: DWM; Step 2: PM+)
EXPERIMENTALThe treatment group will receive the stepped-care program consisting of Doing What Matters (DWM) (step 1) and Problem Management Plus (PM+) (step 2) in addition to Psychological First Aid (PFA) and care-as-usual (CAU). Step 2 will only be provided if the participant still has elevated levels of psychological distress at 2 weeks after DWM, i.e. during the second quantitative assessment at 2 weeks after DWM. Participants allocated to the experimental arm will also receive training in PFA, which consists of a 30-min call that covers basic aspects about peer support in times of stress. Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria.
Psychological First Aid (PFA)
ACTIVE COMPARATORParticipants allocated to the control arm will also receive training in PFA, which consists of a 30-min call that covers basic aspects about peer support in times of stress. Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria.
Interventions
The original DWM program consists of a self-help guide called 'Doing What Matters in Times of Stress', that is complemented with pre-recorded audio exercises. The audio material imparts key information about stress management and guides participants through individual exercises. Additionally, participants are guided by a briefly trained helper. In this study, DWM will be delivered as an online intervention. The DWM intervention, i.e. both the audio recordings and the self-help guide, will be adapted for use on a smartphone or other device with internet access during Phase 1 of RESPOND. The format of DWM is innovative in that it seeks to ensure that key intervention components are delivered as intended through the use of pre-recorded audio, without the burden of extensive training and supervision. In the online application tool a new module is released every week so participants will be asked to go through the entire DWM intervention within 5 weeks with weekly guidance from a helper.
PM+ is a new, brief, psychological intervention program based on cognitive behavioral therapy (CBT) techniques. The manual involves the following empirically supported elements: problem solving plus stress management, behavioral activation, facing fears, and accessing social support. Across the five 90-minute sessions participants may talk to trained non-professional. PM+ has four core features, and it is brief. In this study, the delivery mode of the PM+ intervention will be flexible, with remote delivery in phases of the pandemic when physical distancing rules apply. This is a future-oriented attempt towards a more holistic mental health care system that can flexibly switch between modes of delivery (e.g. remotely (e.g. Zoom) or face-to), depending on the needs and the specific containment measures that apply, and the specific preferences and needs of the participant.
PFA is a brief intervention consisting of providing basic information for peer support in times of emotional distress
Eligibility Criteria
You may qualify if:
- years or older;
- Living in Madrid or Barcelona
- Having elevated levels of psychological distress (Kessler Psychological Distress Scale (K10) \>15.9).
- Written/digital informed consent before entering the study.
You may not qualify if:
- Having acute medical conditions (requiring hospitalization)
- Imminent suicide risk, or expressed acute needs, or protection risks that require immediate follow-up
- Having a severe mental disorder (e.g., psychotic disorders, substance-dependence)
- Having severe cognitive impairment (e.g., severe intellectual disability or dementia)
- Currently specialized psychological treatment (e.g., Eye movement desensitization and reprocessing, Cognitive behavioral therapy)
- In case of current psychotropic medication use, not being on a stable dose during the past 2 months being on an unstable dose for at least 2 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Instituto de Investigación Hospital Universitario La Pazlead
- Universidad Autonoma de Madridcollaborator
- Hospital Universitario La Pazcollaborator
- Parc Sanitari Sant Joan de Déucollaborator
- Fundació Sant Joan de Déucollaborator
- European Commissioncollaborator
- VU University of Amsterdamcollaborator
- World Health Organizationcollaborator
Study Sites (2)
Parc Sanitari Sant Joan de Déu
Sant Boi de Llobregat, Barcelona, 08830, Spain
Hospital Universitario La Paz
Madrid, 28046, Spain
Related Publications (3)
Mediavilla R, Garcia-Vazquez B, McGreevy KR, Underhill J, Bayon C, Bravo-Ortiz MF, Munoz-Sanjose A, Haro JM, Monistrol-Mula A, Nicaise P, Petri-Romao P, McDaid D, Park AL, Melchior M, Vuillermoz C, Turrini G, Compri B, Purgato M, Roos R, Witteveen AB, Sijbrandij M, Bryant RA, Fuhr D, Ayuso-Mateos JL. Beyond effectiveness in eHealth trials: Process evaluation of a stepped-care programme to support healthcare workers with psychological distress (RESPOND-HCWs). Digit Health. 2024 Oct 18;10:20552076241287678. doi: 10.1177/20552076241287678. eCollection 2024 Jan-Dec.
PMID: 39430699DERIVEDMediavilla R, Felez-Nobrega M, McGreevy KR, Monistrol-Mula A, Bravo-Ortiz MF, Bayon C, Gine-Vazquez I, Villaescusa R, Munoz-Sanjose A, Aguilar-Ortiz S, Figueiredo N, Nicaise P, Park AL, Petri-Romao P, Purgato M, Witteveen AB, Underhill J, Barbui C, Bryant R, Kalisch R, Lorant V, McDaid D, Melchior M, Sijbrandij M, Haro JM, Ayuso-Mateos JL; RESPOND Consortium. Effectiveness of a mental health stepped-care programme for healthcare workers with psychological distress in crisis settings: a multicentre randomised controlled trial. BMJ Ment Health. 2023 Jun;26(1):e300697. doi: 10.1136/bmjment-2023-300697.
PMID: 37263708DERIVEDMediavilla R, McGreevy KR, Felez-Nobrega M, Monistrol-Mula A, Bravo-Ortiz MF, Bayon C, Rodriguez-Vega B, Nicaise P, Delaire A, Sijbrandij M, Witteveen AB, Purgato M, Barbui C, Tedeschi F, Melchior M, van der Waerden J, McDaid D, Park AL, Kalisch R, Petri-Romao P, Underhill J, Bryant RA, Haro JM, Ayuso-Mateos JL; RESPOND Consortium. Effectiveness of a stepped-care programme of internet-based psychological interventions for healthcare workers with psychological distress: Study protocol for the RESPOND healthcare workers randomised controlled trial. Digit Health. 2022 Oct 5;8:20552076221129084. doi: 10.1177/20552076221129084. eCollection 2022 Jan-Dec.
PMID: 36211795DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
José Luis Ayuso-Mateos, MD, PhD
Universidad Autonoma de Madrid
- PRINCIPAL INVESTIGATOR
María Fe Bravo-Ortiz, MD, PhD
Hospital Universitario La Paz
- PRINCIPAL INVESTIGATOR
Josep Maria Haro, MD, PhD
Parc Sanitari Sant Joan de Déu
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessor will not know whether a single participant was allocated to the experimental or to the control arm. That will be done by assigning random values toe the variable "arm" in the dataset.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2021
First Posted
July 28, 2021
Study Start
November 3, 2021
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
June 4, 2025
Record last verified: 2021-11